Diagenode

H3K56ac Antibody - ChIP-seq Grade

目录号
格式
价格
C15410213
50 μg
$380.00
  Bulk order
其他格式



Polyclonal antibody raised in rabbit against the region of histone H3 containing the acetylated lysine 56 (H3K56ac), using a KLH-conjugated synthetic peptide.

LotA2069P
Concentration0.8 µg/µl
Species reactivityHuman
TypePolyclonal, ChIP grade/ChIP-seq grade
PurityAffinity purified
HostRabbit
PrecautionsThis product is for research use only. Not for use in diagnostic or therapeutic procedures.
Applications Suggested dilution References
ChIP/ChIP-seq * 5 μg/ChIP Fig 1, 2
Cut&Tag 1 μg Fig 3
ELISA 1:500 Fig 4
Dot Blotting 1:20,000 Fig 5
Western Blotting 1:200 Fig 6

* Please note that the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-5 μg per IP.

  • Validation Data

    H3K56ac Antibody ChIP Grade

    Figure 1. ChIP results obtained with the Diagenode antibody directed against H3K56ac
    ChIP assays were performed using human K562 cells, the Diagenode antibody against H3K56ac (cat. No. C15410213) and optimized PCR primer sets for qPCR. ChIP was performed with the “iDeal ChIP-seq” kit (cat. No. C01010051), using sheared chromatin from 500,000 cells. A titration of the antibody consisting of 1, 2, 5 and 10 µg per ChIP experiment was analysed. IgG (2 µg/IP) was used as negative IP control. QPCR was performed with primers for GAPDH and EIF4A2 promoters, used as positive controls, and for the coding region of the inactive MYOD1 gene and the Sat2 satellite repeat, used as negative controls. Figure 1 shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).

    A.H3K56ac Antibody ChIP-seq Grade

    B.H3K56ac Antibody for ChIP-seq

    C.H3K56ac Antibody for ChIP-seq assay

    D.H3K56ac Antibody validated in ChIP-seq

    Figure 2. ChIP-seq results obtained with the Diagenode antibody directed against H3K56ac
    ChIP was performed on sheared chromatin from 500,000 K562 cells using 1 µg of the Diagenode antibody against H3K56ac (cat. No. C15410213) as described above. The IP’d DNA was subsequently analysed on an Illumina HiSeq. Library preparation, cluster generation and sequencing were performed according to the manufacturer’s instructions. The 51 bp tags were aligned to the human genome using the BWA algorithm. Figure 2 shows the enrichment along the complete sequence and a 1 Mb region of the X-chromosome (fig 2A and B) and in genomic regions of chromosome 12 and 3, surrounding the GAPDH and EIF4A2 positive control genes.

    H3K56ac Antibody Cut and tag

    Figure 3. Cut&Tag results obtained with the Diagenode antibody directed against H3K56ac
    CUT&TAG (Kaya-Okur, H.S., Nat Commun 10, 1930, 2019) was performed on 50,000 K562 cells using 1 µg of the Diagenode antibody against H3K56ac (cat. No. C15410213) and the Diagenode pA-Tn5 transposase (C01070001). The libraries were subsequently analysed on an Illumina NextSeq 500 sequencer (2x75 paired-end reads) according to the manufacturer’s instructions. The tags were aligned to the human genome (hg19) using the BWA algorithm. Figure 3 shows the peak distribution in 2 genomic regions surrounding the FOS gene on chromosome 14 and the CCT5 gene on chromosome 5 (figure 3A and B, respectively).


    H3K56ac Antibody ELISA validation

    Figure 4. Determination of the antibody titer
    To determine the titer of the antibody, an ELISA was performed using a serial dilution of the Diagenode antibody directed against H3K56ac (cat. No. 15410213) in antigen coated wells. The antigen used was a peptide containing the histone modification of interest. By plotting the absorbance against the antibody dilution (Figure 4), the titer of the antibody was estimated to be 1:36,500.

    H3K56ac Antibody validated in Dot Blot

    Figure 5. Cross reactivity tests using the Diagenode antibody directed against H3K56ac
    To test the cross reactivity of the Diagenode antibody against H3K56ac (cat. No. 15410213), a Dot Blot analysis was performed with peptides containing other histone modifications and the unmodified H3K56. One hundred to 0.2 pmol of the respective peptides were spotted on a membrane. The antibody was used at a dilution of 1:20,000. Figure 5 shows a high specificity of the antibody for the modification of interest.

    H3K56ac Antibody validated in Western Blot

    Figure 6.Western blot analysis using the Diagenode antibody directed against H3K56ac
    Western blot was performed on whole cell extracts (40 μg, lane 1) from HeLa cells, and on 1 μg of recombinant histone H3 (lane 2) using the Diagenode antibody against H3K56ac (cat. No. C15410213). The antibody was diluted 1:200 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is indicated on the right; the marker (in kDa) is shown on the left.

  • Target Description

    Histones are the main constituents of the protein part of chromosomes of eukaryotic cells. They are rich in the amino acids arginine and lysine and have been greatly conserved during evolution. Histones pack the DNA into tight masses of chromatin. Two core histones of each class H2A, H2B, H3 and H4 assemble and are wrapped by 146 base pairs of DNA to form one octameric nucleosome. Histone tails undergo numerous post-translational modifications, which either directly or indirectly alter chromatin structure to facilitate transcriptional activation or repression or other nuclear processes. In addition to the genetic code, combinations of the different histone modifications reveal the so-called “histone code”. Histone methylation and demethylation is dynamically regulated by respectively histone methyl transferases and histone demethylases.

  •  应用
    ELISA
    Enzyme-linked immunosorbent assay. Read more
    WB
    Western blot : The quality of antibodies used in this technique is crucial for correct and specific protein identification. Diagenode offers huge selection of highly sensitive and specific western blot-validated antibodies. Learn more about: Load... Read more
    ChIP-seq (ab)
    Read more
    ChIP-qPCR (ab)
    Read more
    CUT&Tag
    Read more
  •  文档
    Datasheet H3K56ac C15410213 DATASHEET
    Datasheet description
    Download
    Antibodies you can trust POSTER
    Epigenetic research tools have evolved over time from endpoint PCR to qPCR to the analyses of lar...
    Download
    Epigenetic Antibodies Brochure BROCHURE
    More than in any other immuoprecipitation assays, quality antibodies are critical tools in many e...
    Download
  •  Safety sheets
    SDS C15410213 H3K56ac Antibody US en Download
    SDS C15410213 H3K56ac Antibody GB en Download
    SDS C15410213 H3K56ac Antibody BE fr Download
    SDS C15410213 H3K56ac Antibody FR fr Download
    SDS C15410213 H3K56ac Antibody ES es Download
    SDS C15410213 H3K56ac Antibody JP ja Download
    SDS C15410213 H3K56ac Antibody DE de Download
    SDS C15410213 H3K56ac Antibody BE nl Download
  •  出版物

    How to properly cite this product in your work

    Diagenode strongly recommends using this: H3K56ac Antibody - ChIP-seq Grade (Diagenode Cat# C15410213 Lot# A2069P). Click here to copy to clipboard.

    Using our products in your publication? Let us know!

    Quantification and epigenetic evaluation of the residual pool of hepatitisB covalently closed circular DNA in long-term nucleoside analogue-treatedpatients.
    Lebossé F. et al.
    Hepatitis B virus (HBV) covalently closed circular (ccc)DNA is the key genomic form responsible for viral persistence and virological relapse after treatment withdrawal. The assessment of residual intrahepatic cccDNA levels and activity after long-term nucleos(t)ide analogues therapy still represents a technical cha...

  •  相关产品

活动

  • APHL 2024
    Milwaukee, Wisconsin, USA
    May 6-May 9, 2024
  • London Calling 2024
    London, UK
    May 21-May 24, 2024
 查看所有活动

新闻

 查看所有新闻


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics